These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24447630)

  • 1. Dual endothelin receptor antagonism with bosentan reverses established vascular remodeling and dysfunctional angiogenesis in diabetic rats: relevance to glycemic control.
    Abdelsaid M; Kaczmarek J; Coucha M; Ergul A
    Life Sci; 2014 Nov; 118(2):268-73. PubMed ID: 24447630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late dual endothelin receptor blockade with bosentan restores impaired cerebrovascular function in diabetes.
    Abdelsaid M; Ma H; Coucha M; Ergul A
    Life Sci; 2014 Nov; 118(2):263-7. PubMed ID: 24434796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linagliptin attenuates diabetes-induced cerebral pathological neovascularization in a blood glucose-independent manner: Potential role of ET-1.
    Abdelsaid M; Williams R; Hardigan T; Ergul A
    Life Sci; 2016 Aug; 159():83-89. PubMed ID: 26631506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes.
    Sachidanandam K; Portik-Dobos V; Kelly-Cobbs AI; Ergul A
    Can J Physiol Pharmacol; 2010 Jun; 88(6):616-21. PubMed ID: 20628426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes-mediated middle cerebral artery remodeling is restored by linagliptin: Interaction with the vascular smooth muscle cell endothelin system.
    Yasir A; Hardigan T; Ergul A
    Life Sci; 2016 Aug; 159():76-82. PubMed ID: 26944436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic endothelin antagonism restores cerebrovascular function in diabetes.
    Dumont AS; Dumont RJ; McNeill JH; Kassell NF; Sutherland GR; Verma S
    Neurosurgery; 2003 Mar; 52(3):653-60; discussion 659-60. PubMed ID: 12590691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors.
    Kelly-Cobbs AI; Harris AK; Elgebaly MM; Li W; Sachidanandam K; Portik-Dobos V; Johnson M; Ergul A
    J Pharmacol Exp Ther; 2011 Apr; 337(1):9-15. PubMed ID: 21205912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes.
    Li W; Sachidanandam K; Ergul A
    Neurol Res; 2011 Mar; 33(2):185-91. PubMed ID: 21801593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1.
    Sachidanandam K; Hutchinson JR; Elgebaly MM; Mezzetti EM; Dorrance AM; Motamed K; Ergul A
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R952-9. PubMed ID: 19176890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus.
    Cayir A; Ugan RA; Albayrak A; Kose D; Akpinar E; Cayir Y; Atmaca HT; Bayraktutan Z; Kara M
    J Endocrinol Invest; 2015 Sep; 38(9):987-98. PubMed ID: 25847324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure-independent cerebrovascular remodelling and changes in myogenic reactivity in diabetic Goto-Kakizaki rat in response to glycaemic control.
    Kelly-Cobbs A; Elgebaly MM; Li W; Ergul A
    Acta Physiol (Oxf); 2011 Sep; 203(1):245-51. PubMed ID: 21092073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endothelin receptor blockade on hypervasoreactivity in streptozotocin-diabetic rats: vessel-specific involvement of thromboxane A2.
    Arikawa E; Cheung C; Sekirov I; Battell ML; Yuen VG; McNeill JH
    Can J Physiol Pharmacol; 2006; 84(8-9):823-33. PubMed ID: 17111027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in cardiac function of diabetic rats by bosentan is not associated with changes in the activation of PKC isoforms.
    Jiang J; Yuen V; Xiang H; McNeill JH
    Mol Cell Biochem; 2006 Jan; 282(1-2):177-85. PubMed ID: 16317525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade.
    Spiers JP; Kelso EJ; Siah WF; Edge G; Song G; McDermott BJ; Hennessy M
    J Hypertens; 2005 Sep; 23(9):1717-24. PubMed ID: 16093917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes.
    Stevens EJ; Tomlinson DR
    Br J Pharmacol; 1995 May; 115(2):373-9. PubMed ID: 7670740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin ET
    Vercauteren M; Trensz F; Pasquali A; Cattaneo C; Strasser DS; Hess P; Iglarz M; Clozel M
    J Pharmacol Exp Ther; 2017 May; 361(2):322-333. PubMed ID: 28223322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes.
    Gilbert RE; Rumble JR; Cao Z; Cox AJ; van Eeden P; Allen TJ; Kelly DJ; Cooper ME
    Circ Res; 2000 Feb; 86(2):158-65. PubMed ID: 10666411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bosentan (ETA/ETB receptor antagonist) on metabolic changes during stress and diabetes.
    Said SA; Ammar el SM; Suddek GM
    Pharmacol Res; 2005 Feb; 51(2):107-15. PubMed ID: 15629255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endothelin receptors and relationship with nitric oxide synthase in impaired erectile response in diabetic rats.
    Alkan E; Ugan RA; Basar MM; Halici Z; Karakus E; Balbay MD; Un H
    Andrologia; 2017 Mar; 49(2):. PubMed ID: 27145076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional estimation of endothelin-1 receptor antagonism by bosentan, macitentan and ambrisentan in human pulmonary and radial arteries in vitro.
    Angus JA; Soeding PF; Hughes RJA; Wright CE
    Eur J Pharmacol; 2017 Jun; 804():111-116. PubMed ID: 28300593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.